BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22569107)

  • 1. The effect of the PQ1 anti-breast cancer agent on normal tissues.
    Ding Y; Prasain K; Nguyen TD; Hua DH; Nguyen TA
    Anticancer Drugs; 2012 Oct; 23(9):897-905. PubMed ID: 22569107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.
    Gakhar G; Hua DH; Nguyen TA
    Anticancer Drugs; 2010 Jan; 21(1):77-88. PubMed ID: 19966541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Apoptosis by PQ1, a Gap Junction Enhancer that Upregulates Connexin 43 and Activates the MAPK Signaling Pathway in Mammary Carcinoma Cells.
    Shishido SN; Nguyen TA
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and efficacy of a gap junction enhancer (PQ7) in a mouse mammary tumor model.
    Shishido SN; Prasain K; Beck A; Nguyen TD; Hua DH; Nguyen TA
    PLoS One; 2013; 8(6):e67174. PubMed ID: 23776708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-breast cancer agents, quinolines, targeting gap junction.
    Bernzweig J; Heiniger B; Prasain K; Lu J; Hua DH; Nguyen TA
    Med Chem; 2011 Sep; 7(5):448-53. PubMed ID: 21801150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticancer effect of PQ1 in the MMTV-PyVT mouse model.
    Shishido SN; Delahaye A; Beck A; Nguyen TA
    Int J Cancer; 2014 Mar; 134(6):1474-83. PubMed ID: 24038078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PQ1, a quinoline derivative, induces apoptosis in T47D breast cancer cells through activation of caspase-8 and caspase-9.
    Ding Y; Nguyen TA
    Apoptosis; 2013 Sep; 18(9):1071-82. PubMed ID: 23677255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of gap junction activities in SW480 human colorectal cancer cells.
    Bigelow K; Nguyen TA
    BMC Cancer; 2014 Jul; 14():502. PubMed ID: 25008544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational treatment of gap junction enhancers and paclitaxel attenuates mammary tumor growth.
    Shishido S; Nguyen TA
    Anticancer Drugs; 2020 Apr; 31(4):353-358. PubMed ID: 31913199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gap Junction Enhancer Potentiates Cytotoxicity of Cisplatin in Breast Cancer Cells.
    Ding Y; Nguyen TA
    J Cancer Sci Ther; 2012 Nov; 4(11):371-378. PubMed ID: 25045421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quinoline derivative PQ1 combined with cisplatin promotes the proliferation and gap junction communication of prostate cancer PC3 cells].
    Lin YZ; Xu N; Li XD; Xue XY; Cai H; Wei Y; Zheng QS
    Zhonghua Nan Ke Xue; 2016 Feb; 22(2):116-21. PubMed ID: 26939394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivity and molecular targets of novel substituted quinolines in murine and human tumor cell lines in vitro.
    Perchellet EM; Crow KR; Gakhar G; Nguyen TA; Shi A; Hua DH; Perchellet JP
    Int J Oncol; 2010 Mar; 36(3):673-88. PubMed ID: 20126988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gap junction enhancer increases efficacy of cisplatin to attenuate mammary tumor growth.
    Shishido SN; Nguyen TA
    PLoS One; 2012; 7(9):e44963. PubMed ID: 23028705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-induced ototoxicity in organotypic cochlear cultures occurs independent of gap junctional intercellular communication.
    Abitbol J; Beach R; Barr K; Esseltine J; Allman B; Laird D
    Cell Death Dis; 2020 May; 11(5):342. PubMed ID: 32393745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gap junction intercellular communication is involved in silica nanoparticles-induced H9c2 cardiomyocytes apoptosis via the mitochondrial pathway.
    Du ZJ; Cui GQ; Zhang J; Liu XM; Zhang ZH; Jia Q; Ng JC; Peng C; Bo CX; Shao H
    Int J Nanomedicine; 2017; 12():2179-2188. PubMed ID: 28356735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid arrests cell cycle in leukemic bone marrow stromal cells by increasing intercellular communication through connexin 43-mediated gap junction.
    Liu Y; Wen Q; Chen XL; Yang SJ; Gao L; Gao L; Zhang C; Li JL; Xiang XX; Wan K; Chen XH; Zhang X; Zhong JF
    J Hematol Oncol; 2015 Oct; 8():110. PubMed ID: 26446715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation substituted quinolines as anticancer drugs for breast cancer.
    Heiniger B; Gakhar G; Prasain K; Hua DH; Nguyen TA
    Anticancer Res; 2010 Oct; 30(10):3927-32. PubMed ID: 21036704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gap junctional intercellular communication by TCDD in HMEC and MCF-7 breast cancer cells.
    Gakhar G; Schrempp D; Nguyen TA
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):171-81. PubMed ID: 19121332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzo[a]pyrene-decreased gap junctional intercellular communication via calcium/calmodulin signaling increases apoptosis in TM4 cells.
    Ji X; Chou X; Ge Z; Ding F; Gao H; Wu Q
    J Appl Toxicol; 2018 Aug; 38(8):1091-1103. PubMed ID: 29578247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis.
    Tekpli X; Rivedal E; Gorria M; Landvik NE; Rissel M; Dimanche-Boitrel MT; Baffet G; Holme JA; Lagadic-Gossmann D
    Toxicol Appl Pharmacol; 2010 Jan; 242(2):231-40. PubMed ID: 19874837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.